Cargando…
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome
We report the clinical and immunological features in a case of SARS-CoV-2-induced Guillain-Barré syndrome (Si-GBS), suggesting that (1) Si-GBS can develop even after paucisymptomatic COVID-19 infection; (2) a distinctive cytokine repertoire is associated with this autoimmune complication, with incre...
Autores principales: | Gigli, Gian Luigi, Vogrig, Alberto, Nilo, Annacarmen, Fabris, Martina, Biasotto, Alessia, Curcio, Francesco, Miotti, Valeria, Tascini, Carlo, Valente, Mariarosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530349/ https://www.ncbi.nlm.nih.gov/pubmed/33006723 http://dx.doi.org/10.1007/s10072-020-04787-7 |
Ejemplares similares
-
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians
por: Vogrig, Alberto, et al.
Publicado: (2022) -
Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era
por: Marini, Alessandro, et al.
Publicado: (2020) -
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
por: Nilo, Annacarmen, et al.
Publicado: (2020) -
Guillain-Barré syndrome associated with COVID-19: an atypical, late-onset presentation
por: Fletman, Elizabeth W., et al.
Publicado: (2021) -
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
por: Trimboli, Michele, et al.
Publicado: (2021)